PropertyValue
?:abstract
  • An amendment to this paper has been published and can be accessed via the original article.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1186/s13063-020-04877-z
?:journal
  • Trials
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/ac689590f3a2233b682c343f18c5bbb9655ad056.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7670989.xml.json
?:pmcid
?:pmid
?:pmid
  • 33203476.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial
?:type
?:year
  • 2020-11-17

Metadata

Anon_0  
expand all